本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

37.44
-2.3550-5.92%
盘后37.440.00000.00%19:54 EDT
成交量:308.93万
成交额:1.16亿
市值:69.61亿
市盈率:-10.47
高:39.60
开:39.33
低:36.36
收:39.80
数据加载中...
2021/03/08

重要事件披露

8-K - Current report
2021/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/01

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]